Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biochimie|May 11, 2025
Caffeine modulates immunoproteasome activity and content in colorectal adenocarcinoma cellsAlexander Burov, Alexander Rezvykh, Valeria Vedernikova, et al.
Journal of Biotechnology|April 15, 2018
Immobilization of microalgae on the surface of new cross-linked polyethylenimine-based sorbentsSvetlana Vasilieva, Karina Shibzukhova, Alexey Morozov, et al.
Cells|June 2, 2021
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with LentivirusesElmira Vagapova, Alexander Burov, Daria Spasskaya, et al.
Frontiers in Immunology|January 1, 2026
Next-generation cell lines for profiling different proteasome forms and their implications in cancerAlexander Burov, Anastasia Yakovleva, Georgy Linovskiy, et al.
International Journal of Molecular Sciences|May 13, 2023
Chronic Administration of Non-Constitutive Proteasome Inhibitor Modulates Long-Term Potentiation and Glutamate Signaling-Related Gene Expression in Murine HippocampusAlexander Maltsev, Sergei Funikov, Alexander Rezvykh, et al.
Oncotarget|September 17, 2017
Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitorsPavel Spirin, Timofey Lebedev, Natalia Orlova, et al.
Cancers|January 11, 2025
Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast CancerIrina Kondakova, Elena Sereda, Evgeniya Sidenko, et al.
Frontiers in Molecular Biosciences|May 22, 2024
Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cellsAlexander Burov, Ekaterina Grigorieva, Timofey Lebedev, et al.
Pharmaceutics|April 26, 2025
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers ApoptosisPavel Spirin, Valeria Vedernikova, Tatsiana Volkava, et al.
Vaccine|May 13, 2008
HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune responseElizaveta S Starodubova, Andreas Boberg, Marina Litvina, et al.
Pageof 3